
Challenges and opportunities with plasma-derived therapies
This newest pharmaphorum podcast welcomes Takeda's Dr Kristina Allikmets.
Newsletters and Deep Dive digital magazine
This newest pharmaphorum podcast welcomes Takeda's Dr Kristina Allikmets.
But unanimous vote on biomarker validity could support accelerated approval of tofersen.
ORION-17 study has been abandoned, with Novartis opting instead for a smaller global trial.
Rapid urine tests could help NHS ensure that antibiotics are used appropriately.
If approved, EAPP could help streamline the journey to diagnosis for patients, say partners.
Editor's Picks
Newsletters and Deep Dive
digital magazine